Clinical Trial Results:
A parallel-group, double-blind, randomized, placebo-controlled,
active comparator, multicenter study to evaluate the efficacy,
safety, tolerability and pharmacokinetics of two doses of
GSK232802 administered orally as monotherapy for 12 weeks
in healthy postmenopausal women with moderate to extremely
severe vasomotor symptoms
Summary
|
|
EudraCT number |
2007-001295-36 |
Trial protocol |
SE DE GB IT ES |
Global completion date |
23 Jul 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
26 Nov 2016
|
First version publication date |
26 Nov 2016
|
Other versions |
|
Summary report(s) |
gsk-105106-synopsis-redact |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.